{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:27:38Z","timestamp":1778851658691,"version":"3.51.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Pleural mesothelioma is a rare and aggressive cancer that affects the pleura. In recent years, there has been increasing interest and attention in detecting and diagnosing early-stage or precancerous forms of mesothelioma because of its severe prognosis and short life expectancy at the time of diagnosis. Mesothelioma <jats:italic toggle=\"yes\">in situ<\/jats:italic> represents a clear opportunity to improve and innovate the diagnostic approach and the multimodality treatment of mesothelioma: the diagnosis of pleural mesothelioma at the \u2018in-situ phase\u2019 means early disease detection and thus paves the way to new possible curable strategies. Since 2021, when mesothelioma <jats:italic toggle=\"yes\">in situ<\/jats:italic> was finally identified and described as a new histological entity, its diagnosis and management became a challenge and the subject of ongoing research; several aspects remain open and still outstanding as regards diagnostic techniques, time and probability of progression, need for and methods of follow up, aggressive and early surgery. This narrative review aims to provide a comprehensive overview of mesothelioma <jats:italic toggle=\"yes\">in situ<\/jats:italic> covering its definition, risk factors, diagnostic criteria, and tricky aspects of early detection. It also highlights its clinical significance, new perspectives, and potential future indications in the context of pleural mesothelioma multidisciplinary management.<\/jats:p>","DOI":"10.1097\/cej.0000000000000883","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T20:00:10Z","timestamp":1711656010000},"page":"545-551","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pleural mesothelioma in situ: a comprehensive review"],"prefix":"10.1097","volume":"33","author":[{"given":"Federica","family":"Danuzzo","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Raveglia","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Maria","family":"Sibilia","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Cassina","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Libretti","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Pirondini","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tuoro","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bono","sequence":"additional","affiliation":[{"name":"Division of Pathology, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Emilia","family":"Paladino","sequence":"additional","affiliation":[{"name":"Unit of Occupational Health, Fondazione IRCCS San Gerardo dei Tintori, Monza"},{"name":"School of Medicine and Surgery, University of Milano Bicocca, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Cortinovis","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano Bicocca, Milan"},{"name":"Division of Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Petrella","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajim.23358","article-title":"Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: a case report.","volume":"65","author":"Almeida","year":"2022","journal-title":"Am J Ind Med"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"ivac255","DOI":"10.1093\/icvts\/ivac255","article-title":"Malignant pleural mesothelioma in situ.","volume":"35","author":"Ando","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","article-title":"Pleural mesothelioma classification update.","volume":"478","author":"Beasley","year":"2021","journal-title":"Virchows Arch"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/CEJ.0000000000000810","article-title":"An evaluation of the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma.","volume":"32","author":"Bertolaccini","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/ijerph19010235","article-title":"Asbestos exposure and malignant mesothelioma in construction workers-epidemiological remarks by the Italian National Mesothelioma Registry (ReNaM).","volume":"19","author":"Binazzi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5858\/arpa.2017-0295-OA","article-title":"Reproducibility of malignant pleural mesothelioma histopathologic subtyping.","volume":"142","author":"Brcic","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5858\/arpa.2021-0331-OA","article-title":"A Combination of MTAP and p16 immunohistochemistry can substitute for CDKN2A fluorescence in situ hybridization in diagnosis and prognosis of pleural mesotheliomas.","volume":"147","author":"Brcic","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy.","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"579327","DOI":"10.3389\/fonc.2020.579327","article-title":"CDKN2A and MTAP are useful biomarkers detectable by droplet digital PCR in malignant pleural mesothelioma: a potential alternative method in diagnosis compared to fluorescence in situ hybridisation.","volume":"10","author":"Cheng","year":"2020","journal-title":"Front Oncol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cncy.22326","article-title":"Testing for BAP1 loss and CDKN2A\/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.","volume":"128","author":"Chevrier","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: new markers and how to use them.","volume":"44","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/his.13468","article-title":"Malignant mesothelioma in situ.","volume":"72","author":"Churg","year":"2018","journal-title":"Histopathology"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome.","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jtho.2020.03.014","article-title":"Malignant mesothelioma in situ: clinical and pathologic implications.","volume":"15","author":"Churg","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas.","volume":"453","author":"Dacic","year":"2008","journal-title":"Virchows Arch"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.3390\/jcm11195544","article-title":"Systematic review and meta-analysis of pleurectomy\/decortication versus extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma.","volume":"11","author":"Danuzzo","year":"2022","journal-title":"J Clin Med"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2016.07.011","article-title":"Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma.","volume":"99","author":"Hamasaki","year":"2016","journal-title":"Lung Cancer"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/pin.13021","article-title":"Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years.","volume":"70","author":"Hidaka","year":"2020","journal-title":"Pathol Int"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000377697","article-title":"Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.","volume":"59","author":"Hjerpe","year":"2015","journal-title":"Acta Cytol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group.","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/PAS.0000000000000176","article-title":"p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma.","volume":"38","author":"Hwang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R24-20250527","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R26-20250527","first-page":"446","article-title":"The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.","volume":"53","author":"Klebe","year":"2021","journal-title":"Pathology (Phila)"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3892\/br.2022.1549","article-title":"Clinical significance of 9P21 gene combined with BAP1 and MTAP protein expression in diagnosis and prognosis of mesothelioma serous effusion.","volume":"17","author":"Ma","year":"2022","journal-title":"Biomed Rep"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.ejca.2007.09.018","article-title":"Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.","volume":"43","author":"Marinaccio","year":"2007","journal-title":"Eur J Cancer"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.3390\/diagnostics12122905","article-title":"New insights in pleural mesothelioma classification update: diagnostic traps and prognostic implications.","volume":"12","author":"Mastromarino","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/dc.25129","article-title":"The cytological features of effusions with mesothelioma in situ: a report of 9 cases.","volume":"51","author":"Michael","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00428-019-02674-x","article-title":"Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report.","volume":"476","author":"Minami","year":"2020","journal-title":"Virchows Arch"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and new frontiers in mesothelioma therapeutics.","volume":"13","author":"Mutti","year":"2018","journal-title":"J Thorac Oncol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.","volume":"15","author":"Nicholson","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00428-022-03281-z","article-title":"Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?","volume":"481","author":"Nishikubo","year":"2022","journal-title":"Virchows Arch"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/jcm11113225","article-title":"Sneaky diagnosis of pleural malignant mesothelioma in thoracic surgery: all that glitters is not gold.","volume":"11","author":"Orlandi","year":"2022","journal-title":"J Clin Med"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606.","volume":"33","author":"Popat","year":"2022","journal-title":"Ann Oncol"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"1310478","DOI":"10.1155\/2017\/1310478","article-title":"Malignant mesothelioma, BAP1 immunohistochemistry, and VEGFA: does BAP1 have potential for early diagnosis and assessment of prognosis?","volume":"2017","author":"Pulford","year":"2017","journal-title":"Dis Markers"},{"key":"R38-20250527","first-page":"635","article-title":"Malignant mesothelioma in situ: diagnostic and clinical considerations.","volume":"52","author":"Pulford","year":"2020","journal-title":"Pathology (Phila)"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification.","volume":"17","author":"Sauter","year":"2022","journal-title":"J Thorac Oncol"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma.","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur Respir J"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma.","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"R42-20250527","first-page":"151","article-title":"The concept of mesothelioma in situ: implications for diagnosis and histogenesis.","volume":"9","author":"Whitaker","year":"1992","journal-title":"Semin Diagn Pathol"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3892\/ol.2022.13560","article-title":"Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report.","volume":"24","author":"Yabuuchi","year":"2022","journal-title":"Oncol Lett"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jtho.2022.06.003","article-title":"Does the amount of asbestos exposure influence prognosis?","volume":"17","author":"Yang","year":"2022","journal-title":"J Thorac Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:00:18Z","timestamp":1748361618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000883","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}